Though first discovered in breast cancer patients, CHEK2 mutations have since been reported to predispose to a range of cancer types, including ovarian, prostate, kidney and colorectal cancers [6], supporting the hypothesis that CHEK2 is a multiorgan cancer susceptibility gene [5]. The gene discussed is CHEK2; the disease is cancer.